Washington set an April 30 deadline for Zambia to hand American corporations preferential access to its copper, cobalt, and lithium reserves or lose HIV treatment funding for 1.3 million people. Today, that deadline expires.
By the close of business today, the government of Zambia must answer a question that no sovereign nation should ever be asked: hand over preferential rights to your mineral wealth, or watch your people die.
The United States has told Zambia to grant American firms preferential access to its mineral resources or risk losing funding that supports HIV treatment for approximately 1.3 million people. The deadline is April 30, 2026. The ultimatum, first reported by The New York Times, has sent shockwaves through African diplomatic circles and has drawn furious condemnation from global health advocates, pan-African movements, and development experts who say Washington has crossed a line that cannot be uncrossed.
A draft memo prepared for US Secretary of State Marco Rubio by the State Department’s Africa Bureau set out the position plainly: Washington would only secure its interests by showing a readiness to withdraw support from Zambia on a large scale. The memo identified Zambia’s copper, cobalt, and lithium deposits as the central demand.
The State Department memo is unambiguous. Staff advised Secretary Rubio that the United States “will only secure our priorities by demonstrating willingness to publicly take support away from Zambia on a massive scale.” The priorities in question are preferential access to Zambia’s copper and cobalt reserves. The support being threatened is antiretroviral treatment for 1.3 million Zambians living with HIV.
The financial arithmetic makes the coercion even more visible. The United States is proposing $320 million for all health programmes in Zambia in 2026, compared with $367 million provided last year for HIV programmes alone a significant reduction being offered in exchange for mineral concessions worth exponentially more. The proposed funding is also expected to decline further in coming years, with Washington considering cuts as early as May if Zambia does not accept the terms.
Beyond minerals, the deal carries an additional demand that has alarmed privacy advocates. Washington negotiators have demanded ten years of access to Zambian health and genetic data, while only offering five years of funding in return. Any potential medications or vaccines developed using this data would not guarantee Zambia a share of the resulting profit. Similar data clauses previously prompted activists in Kenya to launch legal action against their government, and neighbouring Zimbabwe abandoned talks with the US over identical privacy concerns.
Zambia has already been stripped of more than half its annual PEPFAR funding since the Trump administration returned to power last year, through a combination of foreign aid freezes, rescissions, and budget cuts. A survey of 76 HIV clinics across 32 mostly African countries found that, as a result of cuts, many experienced disruptions to testing and treatment, including drug shortages and staff layoffs.
The projections for what a full withdrawal would mean are devastating. Researchers estimated that funding disruptions to PEPFAR just last year resulted in more than 120,000 deaths by November 2025, including more than 13,000 child deaths. A separate study by Imperial College London predicted that just a three-month disruption at the beginning of Trump’s second term would result in more than 37,400 excess deaths by 2060. A full withdrawal affecting over a million people on antiretroviral treatment — would be catastrophic on a scale that dwarfs those figures.
The pressure being applied to Zambia is part of a broader pattern. According to analysis by the nonprofit Partners in Health, health funding under bilateral agreements the Trump administration has been offering African nations would drop by 69% to Rwanda, 61% to Madagascar, 42% to Liberia, and 34% to Eswatini where a quarter of adults live with HIV.
Some countries have already said no. Ghana recently declined a bilateral health agreement with the United States after rejecting terms that required the sharing of sensitive health data, with President John Dramani Mahama’s government taking that position before an April 24, 2026 deadline. The proposed deal would have provided $109 million in US health support to Ghana over five years.
Critics argue that the approach fundamentally conflates two categories of assistance that must remain permanently separate: humanitarian and life-saving assistance, which exists to address human needs, and strategic assistance, which exists to advance economic and national security interests. Conditioning life-saving assistance on mineral concessions does not make PEPFAR strategic it makes strategic assistance look predatory, and it makes the entire U.S. offer less credible.
For the African continent, the Zambia ultimatum is not simply a bilateral dispute. It is a test of whether the sovereignty that African nations formally won in the twentieth century has any practical meaning in the twenty-first or whether the levers of dependency that wealthy nations built through decades of aid can be pulled whenever a resource is coveted.
Read Also: Davido Appointed Head of Youth Mobilisation for His Uncle Adeleke’s Osun Re-election Campaign
HIV and AIDS prevention experts have warned that the administration’s cuts to PEPFAR stand to cause 6.6 million new HIV infections and 4.2 million new AIDS-related deaths between 2025 and 2029. Those are not hypothetical numbers. They are projections built on the lived reality of communities across sub-Saharan Africa where antiretroviral drugs are not optional they are the difference between a parent who comes home and one who does not.
